Making an Impact: Prog Ret Eye Res CXL Review
Our latest review on corneal cross-linking (CXL), published in Progress in Retinal and Eye Research, explores its evolution, advanced protocols like ELZA-PACE, and clinical applications.
Our latest review on corneal cross-linking (CXL), published in Progress in Retinal and Eye Research, explores its evolution, advanced protocols like ELZA-PACE, and clinical applications.
By offering a non-surgical option that improves vision and comfort, mini scleral contact lenses can enhance the quality of life for patients with otherwise challenging visual impairments. Future research could further explore long-term outcomes and compare mini scleral contact lenses with other rehabilitative options to solidify their role in ophthalmic care.
ELZA was represented at the 86th SBAO Symposium in Bern held last weekend by our Consultant Oculoplastic surgeon, Dr. Dr. Dion Paridaens.
The ELZA team were well represented at the CXL Experts’ Meeting 2023, held last weekend at the Mövenpick Hotel, Zurich Airport.
Prof. Farhad Hafezi, Dr. Emilio Torres-Netto and Léonard Kollros were all involved in giving presentations and courses at this conference that contains the world’s leading figures in corneal cross-linking.
Explore the journey of ELZA Institute’s Lead Optometrist, Léonard Kollros, MSc, in earning the distinguished Fellow of the Scleral Lens Education Society (FSLS) title, underscoring his expertise in managing keratoconus with scleral lenses.
The 2nd ELZA Refractive Surgery Course 2023 in Zurich was a nexus of knowledge for FEBOs and advanced residents, providing a comprehensive insight into modern refractive surgery techniques.
Léonard Kollros is the lead Optometrist at the ELZA Institute, and this month, a paper he authored was published in the Journal Français d’Ophtalmologie. It
The 18th CXL Experts’ Meeting, led by ELZA’s CMO, Prof. Farhad Hafezi, was held last weekend in Zurich, Switzerland.
Corneal cross-linking has been shown to be a effective treatment for arresting the progression of keratoconus, and this study adds to the growing body of evidence supporting its use in patients of all ages.
The ELZA Institute had a strong presence at the 82nd SBAO annual congress in Bern. Prof. Kaweh Mansouri, Dr. Emilio Torres-Netto and Ms. Julia Schinzel all
Stay informed & get the newsletter
You have successfully joined our subscriber list.
Newsletter abonnieren & informiert bleiben
Sie haben sich erfolgreich in unsere Abonnentenliste eingetragen.
Bitte bestätigen Sie Ihr Abonnement, indem Sie auf den Link in der E-Mail klicken, die wir Ihnen gerade geschickt haben.